{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:58:32Z","timestamp":1775321912457,"version":"3.50.1"},"reference-count":33,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2022,9,9]]},"DOI":"10.1253\/circrep.cr-22-0070","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T22:10:39Z","timestamp":1661292639000},"page":"422-428","source":"Crossref","is-referenced-by-count":6,"title":["Comorbidities Associated With Residual Cardiovascular Risk in Patients With Chronic Coronary Syndrome Receiving Statin Therapy\u3000\u2015 Subanalysis of the REAL-CAD Trial \u2015"],"prefix":"10.1253","volume":"4","author":[{"given":"Kohei","family":"Wakabayashi","sequence":"first","affiliation":[{"name":"Cardiovascular Center, Showa University Koto-Toyosu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Showa University Fujigaoka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Obara","sequence":"additional","affiliation":[{"name":"Biostatistics Center, Kurume University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuyuki","family":"Kakuma","sequence":"additional","affiliation":[{"name":"Biostatistics Center, Kurume University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Caress Sapporo Hokko Memorial Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Iimuro","sequence":"additional","affiliation":[{"name":"Innovation and Research Support Center, International University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. <i>N Engl J Med<\/i> 2005; 352: 1425\u20131435.","DOI":"10.1056\/NEJMoa050461"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cholesterol Treatment Trialists\u2019 (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials. <i>Lancet<\/i> 2010; 376: 1670\u20131681.","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. <i>N Engl J Med<\/i> 2015; 372: 2387\u20132397.","DOI":"10.1056\/NEJMoa1410489"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. <i>N Engl J Med<\/i> 2017; 376: 1713\u20131722.","DOI":"10.1056\/NEJMoa1615664"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fitchett DH, Leiter LA, Lin P, Pickering J, Welsh R, Stone J, et al. Update to evidence-based secondary prevention strategies after acute coronary syndrome. <i>CJC Open<\/i> 2020; 2: 402\u2013415.","DOI":"10.1016\/j.cjco.2020.04.002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cho KI, Yu J, Hayashi T, Han SH, Koh KK. Strategies to overcome residual risk during statins era. <i>Circ J<\/i> 2019; 83: 1973\u20131979.","DOI":"10.1253\/circj.CJ-19-0624"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. <i>Eur Heart J<\/i> 2020; 41: 407\u2013477.","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ando H, Yamaji K, Kohsaka S, Ishii H, Wada H, Yamada S, et al. Japanese Nationwide PCI (J-PCI) Registry annual report 2019: Patient demographics and in-hospital outcomes. <i>Cardiovasc Interv Ther<\/i> 2022; 37: 243\u2013247.","DOI":"10.1007\/s12928-021-00832-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nakano S, Kohsaka S, Chikamori T, Fukushima K, Kobayashi Y, Kozuma K, et al. JCS 2022 guideline focused update on diagnosis and treatment in patients with stable coronary artery disease. <i>Circ J<\/i> 2022; 86: 882\u2013915.","DOI":"10.1253\/circj.CJ-21-1041"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, et al. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. <i>Circ J<\/i> 2019; 83: 1085\u20131196.","DOI":"10.1253\/circj.CJ-19-0133"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, et al. High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): A randomized superiority trial. <i>Circulation<\/i> 2018; 137: 1997\u20132009.","DOI":"10.1161\/CIRCULATIONAHA.117.032615"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. <i>Circulation<\/i> 1975; 51: 5\u201340.","DOI":"10.1161\/01.CIR.51.4.5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zhang H, Holford T, Bracken MB. A tree-based method of analysis for prospective studies. <i>Stat Med<\/i> 1996; 15: 37\u201349.","DOI":"10.1002\/(SICI)1097-0258(19960115)15:1<37::AID-SIM144>3.0.CO;2-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zhang HP, Bracken MB. A tree-based risk factor analysis of preterm delivery and small for gestational age birth. <i>Am J Epidemiol<\/i> 1995; 141: 70\u201378.","DOI":"10.1093\/oxfordjournals.aje.a117347"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wakabayashi K, Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, et al. Efficacy of statin therapy in inducing coronary plaque regression in patients with low baseline cholesterol levels. <i>J Atheroscler Thromb<\/i> 2016; 23: 1055\u20131066.","DOI":"10.5551\/jat.34660"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: A systematic review and meta-analysis. <i>JAMA<\/i> 2018; 319: 1566\u20131579.","DOI":"10.1001\/jama.2018.2525"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. <i>Lancet<\/i> 2016; 387: 957\u2013967.","DOI":"10.1016\/S0140-6736(15)01225-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: An international cohort study. <i>Lancet<\/i> 2016; 388: 2142\u20132152.","DOI":"10.1016\/S0140-6736(16)31326-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. B\u00f6hm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: Results from ONTARGET and TRANSCEND trials. <i>Lancet<\/i> 2017; 389: 2226\u20132237.","DOI":"10.1016\/S0140-6736(17)30754-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis. <i>CMAJ<\/i> 2013; 185: 949\u2013957.","DOI":"10.1503\/cmaj.121468"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and end-stage renal disease in men. <i>N Engl J Med<\/i> 1996; 334: 13\u201318.","DOI":"10.1056\/NEJM199601043340103"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sarwar N, Gao P, Seshasai SRK, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. <i>Lancet<\/i> 2010; 375: 2215\u20132222.","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. <i>N Engl J Med<\/i> 2008; 358: 2545\u20132559.","DOI":"10.1056\/NEJMoa0802743"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. <i>N Engl J Med<\/i> 2008; 358: 2560\u20132572.","DOI":"10.1056\/NEJMoa0802987"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. <i>N Engl J Med<\/i> 2009; 360: 129\u2013139.","DOI":"10.1056\/NEJMoa0808431"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Miyagi M, Ishii H, Murakami R, Isobe S, Hayashi M, Amano T, et al. Impact of renal function on coronary plaque composition. <i>Nephrol Dial Transplant<\/i> 2010; 25: 175\u2013181.","DOI":"10.1093\/ndt\/gfp423"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kono K, Fujii H, Nakai K, Goto S, Shite J, Hirata K, et al. Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. <i>Kidney Int<\/i> 2012; 82: 344\u2013351.","DOI":"10.1038\/ki.2012.118"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: The Hisayama study. <i>Am J Kidney Dis<\/i> 2010; 55: 21\u201330.","DOI":"10.1053\/j.ajkd.2009.06.034"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. <i>Kidney Int Suppl<\/i> 2020; 98: S1\u2013S115.","DOI":"10.1016\/j.kint.2020.06.019"},{"key":"30","unstructured":"30. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. <i>Kidney Int Suppl<\/i> 2021; 100: S1\u2013S276."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Barratt J, Floege J. SGLT-2 inhibition in IgA nephropathy: The new standard of care. <i>Kidney Int<\/i> 2021; 100: 24\u201326.","DOI":"10.1016\/j.kint.2021.04.002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wheeler DC, Toto RD, Stef\u00e1nsson BV, Jongs N, Chertow GM, Greene T, et al. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy. <i>Kidney Int<\/i> 2021; 100: 215\u2013224.","DOI":"10.1016\/j.kint.2021.03.033"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ridker PM, MacFadyen JG, Glynn RJ, Koenig W, Libby P, Everett BM, et al. Inhibition of interleukin-1\u03b2 by canakinumab and cardiovascular outcomes in patients with chronic kidney disease. <i>J Am Coll Cardiol<\/i> 2018; 71: 2405\u20132414.","DOI":"10.1016\/j.jacc.2018.03.490"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/4\/9\/4_CR-22-0070\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T04:25:07Z","timestamp":1662783907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/4\/9\/4_CR-22-0070\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-22-0070","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"article-number":"CR-22-0070"}}